24/7 Patient Assistance: 760-405-8205

Fernando Miranda, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer

Hospitals & Clinics

  • Education & Training

    dept_icon

    St Francis Medical Center

    Residency

    dept_icon

    College of Georgia

    Fellowship

    dept_icon

    Vanderbilt University ,

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

  • Publications & Memberships

    Dr. Fernando Miranda has contributed to 3 publications.

    A Phase I trial of protracted oral fixed-dose temozolomide.

    Jones, S.F., Greco, F.A., Gian, V.G., Miranda, F.T., Raefsky, E.L., Hainsworth, J.D., Willcutt, N.T., Beschorner, A.F., Kennerly, G., Burris, H.A.; Cancer. 2005 Nov 1.

    See more >>

    Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

    Jones, S.F., Burris, H.A., Hainsworth, J.D., Yardley, D.A., Raefsky, E.A., Miranda, F.T., Kuzur, M.E., Willcutt, N.T., White, M.B., Greco, F.A.; Oncology (Williston Park). 2003 May.

    See more >>

    Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

    Jones, S.F., Gian, V.G., Greco, F.A., Miranda, F.T., Shipley, D.L., Thompson, D.S., Hainsworth, J.D., Toomey, M.A., Willcutt, N.T., Burris, H.A.; Oncology (Williston Park). 2003 May.

    See more >>